Avinger Inc. (AVGR)
Symbol Info
Listed Symbol AVGR
Name Avinger Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $7,915,000
Latest Fiscal EPS $-85.73
Price Info
21 Day Moving Average $1.9045
21 Day EMA $1.982370
50 Day Moving Average $2.9293
50 Day EMA $2.850830
200 Day EMA $8.000570
200 Day Moving Average 4.469950
52 Week High $16.50
52 Week Low $1.41
52 Week Change $-85.862100
Alpha -0.086550
Beta 1.4759
Standard Deviation 0.303960
R2 0.029851
Periods 55
Share Information
10 Day Average Volume 280,797
20 Day Average Volume 301,516
30 Day Average Volume 357,457
50 Day Average Volume 327,130
Outstanding Shares 6,424,965
Float Shares 6,263,740
Percent Float 97.49%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 36
Institute Holdings Date 2019-07-31
Institute Bought Previous 3 Months 590,402
Institute Holdings Percent 6.000000
Institute Sold Previous 3 Months 126,812
Insider Holdings Date 2019-07-31
Insider Bought Previous 3 Months 11,688
Insider Holdings Percent 2.50%
Insider Sold Previous 3 Months -
Insiders Shares Owned 161,225
Price Change
7 Day Price Change $-0.15
7 Day Percent Change -8.38%
21 Day Price Change $-0.7199999
21 Day Percent Change -30.51%
30 Day Price Change $-1.12
30 Day Percent Change -40.58%
Month To Date Price Change $-0.56
Month To Date Percent -25.45%
90 Day Price Change $-3.26
90 Day Percent Change -66.53%
Quarter To Date $-1.39
Quarter To Date Percent -45.87%
180 Day Price Change $-2.749
180 Day Percent Change -62.63%
200 Day Price Change $-1.89
200 Day Percent Change -53.54%
Year To Date $-1.36
Year To Date Percent -45.33%
Profile
Description Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, Wildcat, Kittycat, and the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, and Pantheris, an image-guided atherectomy device, designed to allow physicians to remove arterial plaque in PAD patients. The company manufactures and sells the products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.
Details
Issue Type CS
Market Cap $10,536,943
Sec Type EQS
Auditor Moss Adams LLP
Total Shares Outstanding 6,424,965
CEO Jeffrey M. Soinski
Employees 75
Last Audit UE
Classification
CIK 0001506928
Industry Medical Devices
Sector Healthcare
NAICS Surgical and Medical Instrument Manufacturing(339112)
Info
Address 400 Chesapeake Drive
Redwood City, CA 94063
Website http://www.avinger.com
Facisimile
Telephone +1 650 241-7900
Email ir@avinger.com
Key Ratios
Profitability
EBIT Margin -241.4
EBITDA Margin -226.9
Pre-Tax Profit Margin -371.5
Profit Margin Cont -
Gross Margin 26.70
Profit Margin TOT -
Income Statements
Revenue $8,207,000
Revenue Per Share $1.2774
Revenue 3 Years $-21.81
Revenue 5 Years $-9.94
Valuation Measures
PE Ratio 0.90
Enterprise Value $8,808,946
Price To Sales 1.283897
Price To Free Cash -0.6
PE High Last 5 Years -
Price To Book 1.0
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 1.0
Financial Strength
Total Debt To Equity 1.4
Int Coverage -14.4
Current Ratio 1.5
Leverage Ratio 2.6
Quick Ratio 1.1
Long Term Debt To Capital 0.31
Assets
Receivables Turnover 2.5
Invoice Turnover 1.60
Assets Turnover 0.20
Management Effectiveness
Return Assets -102.58
Return On Equity -298.52
Return On Capital -123.05
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
AVGR
Avinger
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.